Stock Price
9.38
Daily Change
-0.02 -0.21%
Monthly
0.64%
Yearly
37.54%
Q1 Forecast
9.00

Grifols reported EUR2.53B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
Grifols EUR 2.53B 182.67M Sep/2025